Analysts Hike Target Prices For Piramal Enterprises After Carlyle Deal
Billionaire Ajay Piramal, chairman of Piramal Group, speaks during an interview in Mumbai, India. (Photographer: Dhiraj Singh/Bloomberg)  

Analysts Hike Target Prices For Piramal Enterprises After Carlyle Deal

Analysts raised their target prices for Piramal Enterprises Ltd. after Carlyle Group agreed to pick up a stake in Ajay Piramal’s pharmaceutical business.The private equity fund will pay about $490 ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.